ES2067206T3 - Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria. - Google Patents

Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.

Info

Publication number
ES2067206T3
ES2067206T3 ES91830275T ES91830275T ES2067206T3 ES 2067206 T3 ES2067206 T3 ES 2067206T3 ES 91830275 T ES91830275 T ES 91830275T ES 91830275 T ES91830275 T ES 91830275T ES 2067206 T3 ES2067206 T3 ES 2067206T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
epsilon
amino
learning process
caprolactamas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91830275T
Other languages
English (en)
Inventor
Orlando Ghirardi
Roberto Cozzolino
Fabio Giannessi
Domenico Misiti
Maria Ornella Tinti
Carlo Scolastico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2067206T3 publication Critical patent/ES2067206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICA PARA MEJORAR EL PROCESO DE APRENDIZAJE, QUE CONTIENEN COMO PRINCIPIO ACTIVO UNA 3-AMINO-EPSILON -CAPROLACTAMA DE FORMULA (1) EN LA QUE R ES ELEGIDO ENTRE EL GRUPO QUE CONSISTE EN HIDROGENO, FORMILO Y ACETILO. LAS COMPOSICIONES FARMACEUTICAS SE PUEDEN ADMINISTRAR POR VIA ORAL O PARENTERAL EN FORMA DE DOSIS UNITARIA Y COMPRENDEN APROXIMADAMENTE ENTRE 100 Y 500 MG DE UN COMPUESTO DE FORMULA (1).
ES91830275T 1990-06-21 1991-06-20 Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria. Expired - Lifetime ES2067206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04808690A IT1247697B (it) 1990-06-21 1990-06-21 Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria.

Publications (1)

Publication Number Publication Date
ES2067206T3 true ES2067206T3 (es) 1995-03-16

Family

ID=11264445

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91830275T Expired - Lifetime ES2067206T3 (es) 1990-06-21 1991-06-20 Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.

Country Status (8)

Country Link
US (1) US5166150A (es)
EP (1) EP0462948B1 (es)
JP (1) JPH05310575A (es)
AT (1) ATE116855T1 (es)
DE (1) DE69106600T2 (es)
DK (1) DK0462948T3 (es)
ES (1) ES2067206T3 (es)
IT (1) IT1247697B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254471B (it) * 1992-02-27 1995-09-25 Magis Farmaceutici Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
EP0724570B1 (en) * 1993-10-21 1999-03-03 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
US6011028A (en) * 1995-04-20 2000-01-04 G.D. Searle & Co. Cyclic amidino agents useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
CA2333691A1 (en) 1998-06-10 1999-12-16 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63283591A (ja) * 1986-12-17 1988-11-21 Toray Ind Inc Ｌ−α−アミノ−ε−カプロラクタムの製造法

Also Published As

Publication number Publication date
JPH05310575A (ja) 1993-11-22
DE69106600T2 (de) 1995-05-18
EP0462948A3 (en) 1992-03-04
EP0462948B1 (en) 1995-01-11
ATE116855T1 (de) 1995-01-15
DK0462948T3 (da) 1995-03-20
DE69106600D1 (de) 1995-02-23
EP0462948A2 (en) 1991-12-27
US5166150A (en) 1992-11-24
IT9048086A1 (it) 1991-12-21
IT9048086A0 (it) 1990-06-21
IT1247697B (it) 1994-12-30

Similar Documents

Publication Publication Date Title
ES2186737T3 (es) Composiciones de oxicodona de liberacion controlada.
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
CR6643A (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
ES2059786T3 (es) Composicion blanqueante.
CO5410187A1 (es) Formulacion oral de dosis unica de espinosad
ES2061848T3 (es) Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
DE69231298D1 (de) Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
ES2078019T3 (es) Amidas de alcanoil l-carnitina con aminoacidos y composiciones farmaceuticas que las contienen para promover regeneracion del tejido nervioso, inhibir degeneracion neuronal, mejorar el proceso de aprendimiento y memoria y para el tratamiento de coma.
ATE84045T1 (de) Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
ES2175663T3 (es) Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
ES2067206T3 (es) Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.
ES2142430T3 (es) Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
AR035429A1 (es) Kit y composicion farmaceutica que contienen compuestos quimioterapeuticos
ES2078838B1 (es) Procedimiento para preparar una composicion farmaceutica a base de clozapina.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
ES2081463T3 (es) 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
ES2039460T3 (es) Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
KR880700805A (ko) 기능성 유기 염기를 주제로 하는 뇌질환 치료용 제약 조성물
CO5271647A1 (es) Metodo para prevenir la diarrea

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462948

Country of ref document: ES